• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quintiles names global head of clinical & data operations

Quintiles names global head of clinical & data operations

October 11, 2011
CenterWatch Staff

Quintiles has named Steven Skolsky global head of its clinical & data operations (CDO) unit, the core of the company’s clinical development division that monitors the clinical conduct at research sites and collects and manages data from thousands of patients in hundreds of clinical trials conducted around the world.

A 30-year veteran of the biopharmaceutical industry, Skolsky will lead the 5,000-employee CDO unit, which unites clinical data management and clinical operations under one umbrella to accelerate data flow and ensure the quality of Quintiles’ data.

“Steve’s deep knowledge of the industry and proven leadership capabilities will enable Quintiles to increase the value that we deliver to customers in today’s rapidly changing environment we call the New Health,” said Paula Brown Stafford, president of clinical development at Quintiles.

Skolsky previously served as vice chairman of the board and is a current board director for Basilea Pharmaceutica, a Basel, Switzerland-based pharmaceutical company. He also serves as a member of the board of directors for Adherex Technologies.  Most recently, he was principal at Expis Partners, a strategic life science consultancy. He previously served as president and chief executive officer of Sequoia Pharmaceuticals and chief executive officer of Trimeris, and spent more than 20 years at GlaxoSmithKline in a range of senior leadership roles.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing